1. Home
  2. NMAI vs CTKB Comparison

NMAI vs CTKB Comparison

Compare NMAI & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMAI
  • CTKB
  • Stock Information
  • Founded
  • NMAI 2021
  • CTKB 1990
  • Country
  • NMAI United States
  • CTKB United States
  • Employees
  • NMAI N/A
  • CTKB N/A
  • Industry
  • NMAI Investment Managers
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • NMAI Finance
  • CTKB Health Care
  • Exchange
  • NMAI Nasdaq
  • CTKB Nasdaq
  • Market Cap
  • NMAI 429.9M
  • CTKB 433.8M
  • IPO Year
  • NMAI N/A
  • CTKB 2021
  • Fundamental
  • Price
  • NMAI $13.00
  • CTKB $4.99
  • Analyst Decision
  • NMAI
  • CTKB Hold
  • Analyst Count
  • NMAI 0
  • CTKB 4
  • Target Price
  • NMAI N/A
  • CTKB $5.88
  • AVG Volume (30 Days)
  • NMAI 74.8K
  • CTKB 909.9K
  • Earning Date
  • NMAI 01-01-0001
  • CTKB 11-05-2025
  • Dividend Yield
  • NMAI 13.14%
  • CTKB N/A
  • EPS Growth
  • NMAI N/A
  • CTKB N/A
  • EPS
  • NMAI 0.64
  • CTKB N/A
  • Revenue
  • NMAI N/A
  • CTKB $196,828,000.00
  • Revenue This Year
  • NMAI N/A
  • CTKB N/A
  • Revenue Next Year
  • NMAI N/A
  • CTKB $7.25
  • P/E Ratio
  • NMAI $19.03
  • CTKB N/A
  • Revenue Growth
  • NMAI N/A
  • CTKB N/A
  • 52 Week Low
  • NMAI $10.60
  • CTKB $2.37
  • 52 Week High
  • NMAI $12.55
  • CTKB $7.30
  • Technical
  • Relative Strength Index (RSI)
  • NMAI 47.89
  • CTKB 71.50
  • Support Level
  • NMAI $13.05
  • CTKB $4.57
  • Resistance Level
  • NMAI $13.39
  • CTKB $4.96
  • Average True Range (ATR)
  • NMAI 0.14
  • CTKB 0.26
  • MACD
  • NMAI -0.01
  • CTKB 0.08
  • Stochastic Oscillator
  • NMAI 24.37
  • CTKB 99.70

About NMAI Nuveen Multi-Asset Income Fund of Beneficial Interest

Nuveen Multi-Asset Income Fund is a closed-end management investment company. The Fund dynamically invests in a portfolio of equity and debt securities of issuers located around the world. This dynamic investment uses a risk-based framework in which any amount can be allocated to an asset-class at any time. The Fund may invest in equity and debt securities of any type without limit.

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

Share on Social Networks: